Eclipse Myopia Control System

Eclipse Myopia Control System hero

Global Need and Global Opportunity

Eclipse Myopia Control System Eclipse PBM

Not For Commercial Sale / Under Development / Will Require FDA Approval
US and Foreign Patents Granted or Pending

The Eclipse Myopia Control System is under development. The Eclipse PBM System is designed to be a home-based system used for ~2 minutes 2X per day. The child’s use of the system, as well as the health of the child’s eyes, are managed by the child’s Eye Care Professional. Recently a third-party 6-month pilot clinical used a system comprising ~650nm PBM light along with macular protective features similar to those of the Eclipse PBM System. This third party 6-month pilot clinical achieved a slowing of myopia of ~84%. It is believed (and needs to be proven) that with the addition of low level ~480nm blue light that targets the peripheral retina (known to generate retinal dopamine), the Eclipse PBM Myopia Control System should achieve a myopia slowing efficacy of greater than 84%.
Eclipse Myopia Control System Eclipse Ocular Light Therapy with Macular Protection
Eclipse Myopia Control System PBM Benefits in Slowing Myopia

Not For Commercial Sale / Under Development / Will Require FDA Approval
US and Foreign Patents Granted or Pending

Eclipse Myopia Control System Important Facts

Not For Commercial Sale / Under Development / Will Require FDA Approval
US and Foreign Patents Granted or Pending

Eclipse Myopia Control System Major Competitive Advantage

Calculations; A laptop was chosen for the illustration due to the popularity and use with school age children. The working distance was set at 15 inches from the child’s eyes. Binocular vision and fusion are assumed. The eye rotation before head-turn through the myopia control lenses was calculated through a 9mm aperture on the front surface of the myopia control lens worn by the child. Such a calculation takes into consideration the distance from the front aperture / central zone of the myopia control lens worn by the child to the pupillary plane of the child’s eyes.

Not For Commercial Sale / Under Development / Will Require FDA Approval
US and Foreign Patents Granted or Pending

Eclipse Myopia Control System Happy Patients Happy ECPs Happy Company

Not For Commercial Sale / Under Development / Will Require FDA Approval
US and Foreign Patents Granted or Pending